Octagon Capital Advisors

Octagon Capital Advisors as of Dec. 31, 2023

Portfolio Holdings for Octagon Capital Advisors

Octagon Capital Advisors holds 33 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apellis Pharmaceuticals (APLS) 26.9 $168M 2.8M 59.86
Cymabay Therapeutics 10.1 $63M 2.7M 23.62
Verona Pharma Sponsored Ads (VRNA) 7.5 $47M 2.4M 19.88
Insmed Com Par $.01 (INSM) 6.4 $40M 1.3M 30.99
Arcus Biosciences Incorporated (RCUS) 5.7 $36M 1.9M 19.10
Bridgebio Pharma (BBIO) 4.6 $29M 707k 40.37
Celldex Therapeutics Com New (CLDX) 4.5 $28M 708k 39.66
Roivant Sciences SHS (ROIV) 4.5 $28M 2.5M 11.23
Alpine Immune Sciences (ALPN) 3.8 $24M 1.2M 19.06
Structure Therapeutics Sponsored Ads (GPCR) 2.7 $17M 414k 40.76
Centessa Pharmaceuticals Sponsored Ads (CNTA) 2.6 $16M 2.1M 7.96
An2 Therapeutics (ANTX) 2.2 $14M 665k 20.49
Miragen Therapeutics (VRDN) 2.2 $14M 620k 21.78
Immunovant (IMVT) 1.8 $12M 273k 42.13
Dyne Therapeutics (DYN) 1.7 $11M 793k 13.30
Cytokinetics Com New (CYTK) 1.5 $9.7M 116k 83.49
Annexon (ANNX) 1.5 $9.3M 2.1M 4.54
Aerovate Therapeutics (AVTE) 1.5 $9.1M 404k 22.63
Gossamer Bio (GOSS) 1.3 $8.4M 9.2M 0.91
Rapt Therapeutics (RAPT) 1.2 $7.3M 292k 24.85
Glycomimetics (GLYC) 1.1 $7.1M 3.0M 2.36
Gracell Biotechnologies Sponsored Ads 1.0 $6.0M 597k 10.04
Dianthus Therapeutics (DNTH) 0.9 $5.8M 554k 10.40
Reneo Pharmaceuticals (RPHM) 0.6 $3.6M 2.3M 1.60
Jasper Therapeutics 0.6 $3.5M 4.5M 0.79
Female Health (VERU) 0.4 $2.7M 3.8M 0.72
Anaptysbio Inc Common (ANAB) 0.4 $2.6M 120k 21.42
Inozyme Pharma (INZY) 0.3 $1.7M 400k 4.26
Nuvation Bio Com Cl A (NUVB) 0.2 $1.5M 1.0M 1.51
Xilio Therapeutics (XLO) 0.2 $982k 1.8M 0.55
Mirum Pharmaceuticals (MIRM) 0.1 $738k 25k 29.52
Phathom Pharmaceuticals (PHAT) 0.1 $457k 50k 9.13
Aclaris Therapeutics (ACRS) 0.0 $105k 100k 1.05